BioPharma Credit (BPCR) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free BPCR Stock Alerts GBX 0.88 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisChartCompetitorsDividendHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 22, 2024 | markets.businessinsider.comBuy Rating Affirmed for Benitec Biopharma Following Promising BB-301 Trial Results and Financial BoostMarch 28, 2024 | insidertrades.comSapna Shah Acquires 20,000 Shares of BioPharma Credit (LON:BPCR) StockFebruary 26, 2024 | nz.finance.yahoo.comBioPharma Credit PLC (BPCP.L)February 22, 2024 | finance.yahoo.comInvestors in BioPharma Credit (LON:BPCR) have seen notable returns of 40% over the past five yearsFebruary 7, 2024 | realmoney.thestreet.comBiopharma Credit just downgraded at Jefferies, here's whyJanuary 9, 2024 | markets.businessinsider.comAssessing Ambrx Biopharma: Insights From 7 Financial AnalystsJanuary 8, 2024 | finance.yahoo.comBioPharma Credit Ord (BPCR.L)January 2, 2024 | lse.co.ukBioPharma Credit to fund LumiraDx ahead of acquisition by RocheDecember 3, 2023 | finance.yahoo.comBioPharma Credit PLC (LON:BPCR) Looks Interesting, And It's About To Pay A DividendOctober 4, 2023 | msn.comTruist Securities Downgrades POINT Biopharma Global (PNT)September 19, 2023 | lse.co.ukBioPharma Credit notes liquidity amendments to LumiraDX loan dealSeptember 12, 2023 | benzinga.comConnect Biopharma Reports First Half 2023 Financial Results and Provides Business UpdateAugust 27, 2023 | finance.yahoo.comInvesting in BioPharma Credit (LON:BPCR) five years ago would have delivered you a 19% gainAugust 24, 2023 | finanznachrichten.deLumiraDx Inc: LumiraDx Reports Second Quarter 2023 ResultsAugust 16, 2023 | forbes.comBest Credit Cards For Recent College Graduates In August 2023August 2, 2023 | marketwatch.comABVC Biopharma Shares Drop 15% After Big Rise TuesdayJuly 25, 2023 | msn.comCantor Fitzgerald Maintains Reata Pharmaceuticals Inc - (RETA) Overweight RecommendationJuly 23, 2023 | forbes.comBest Mobile Credit Card Readers Of 2023July 6, 2023 | msn.comTD Cowen Initiates Coverage of Reata Pharmaceuticals Inc - (RETA) with Outperform RecommendationJune 26, 2023 | msn.comDRI Healthcare Trust says CTI BioPharma repaid $54.8M debtJune 21, 2023 | cnbc.comThis stock could become a 'one-stop shop' for biopharma and rally more than 35%, RBC saysMay 3, 2023 | msn.comHear how Cambrian BioPharma is reinventing drug (and drug company) developmentApril 23, 2023 | finance.yahoo.comBioPharma Credit PLC (LON:BPCR) Passed Our Checks, And It's About To Pay A US$0.018 DividendMarch 20, 2023 | finance.yahoo.comBioPharma Credit's (LON:BPCR) investors will be pleased with their notable 42% return over the last three yearsMarch 13, 2023 | marketwatch.comAmbrx Biopharma Shares Rise 7% After Completing ATM ProgramFebruary 19, 2023 | msn.comThe next big wave of patent cliffs is ahead; expect biopharma M&A to rise – reportFebruary 13, 2023 | marketwatch.comHillstream BioPharma Shares Rise 15% After Licensing DealFebruary 13, 2023 | msn.comBenzinga's Top Ratings Upgrades, Downgrades For February 13, 2023February 10, 2023 | marketwatch.comHillstream BioPharma Shares Soar on Positive Lung Cancer Treatment ResultsFebruary 7, 2023 | technews.tmcnet.comFirst Wave BioPharma Regains Compliance With Nasdaq's Minimum Bid Price RequirementJanuary 31, 2023 | marketwatch.comHillstream BioPharma Shares Double After Option Agreement With Dana-Farber Cancer InstituteJanuary 15, 2023 | reuters.comBPCR.L - | Stock Price & Latest News | ReutersDecember 5, 2022 | technews.tmcnet.comFirst Wave BioPharma Announces Initial Clinical Sites for its Phase 2 Trial of Enhanced Microgranule Delivery Formulation of AdrulipaseOctober 1, 2022 | finance.yahoo.comInvestors in BioPharma Credit (LON:BPCR) have made a return of 19% over the past five yearsAugust 21, 2022 | finance.yahoo.comBioPharma Credit PLC (LON:BPCR) Goes Ex-Dividend SoonAugust 19, 2022 | finance.yahoo.comBioPharma Credit (LON:BPCR) Has Announced A Dividend Of $0.0175August 17, 2022 | uk.finance.yahoo.comBioPharma Credit PLC (BPCR.L)August 9, 2022 | msn.comWhy CTI BioPharma Stock Got Rocked on TuesdayAugust 9, 2022 | proactiveinvestors.comPfizer to buy Global Blood Therapeutics for US$5.4bnAugust 8, 2022 | finance.yahoo.comIs Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?July 18, 2022 | finance.yahoo.comBioPharma Credit PLC's (LON:BPCR) Popularity With Investors Is Under Threat From OverpricingJune 23, 2022 | finance.yahoo.comDEM BioPharma Launches with $70 Million FinancingJune 23, 2022 | msn.comDEM BioPharma launches with $70m to take a bite out of cancerJune 2, 2022 | yahoo.comHillstream BioPharma Provides Corporate UpdateMay 12, 2022 | apnews.comABVC BioPharma, Inc. Announces $4.22 Million Registered Direct OfferingApril 20, 2022 | marketwatch.comBioPharma Credit Shareholder to Sell 55 Mln Shares via Bookbuild ProgramMarch 8, 2022 | marketwatch.comBioPharma Credit to Invest Up to $50 Mln in UroGen PharmaFebruary 3, 2022 | lse.co.ukBiopharma Cred. Share ChatSeptember 10, 2021 | marketwatch.comBioPharma Credit to Apply for Admission to Listing on LSE Main Market's Premium SegmentAugust 30, 2021 | proactiveinvestors.comBioPharma Credit PLC - Holding(s) in Company Get BioPharma Credit News Delivered to You Automatically Sign up to receive the latest news and ratings for BPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (Ad)Revolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 2024 BPCR Media Mentions By Week BPCR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPCR News Sentiment▼0.000.81▲Average Financial Services News Sentiment BPCR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPCR Articles This Week▼00▲BPCR Articles Average Week Get BioPharma Credit News Delivered to You Automatically Sign up to receive the latest news and ratings for BPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Alpha Growth News KRM22 News Adams News London Finance & Investment Group News Tetragon Financial News Princess Private Equity News i(x) Net Zero News Tekcapital News Tanfield Group News Investment News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:BPCR) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHow Biden has already won 2024Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsWhy Is Gold On a MASSIVE rally? Huge AlertsAmericans Now Need $1.46M to Retire…Crypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
